Intravitreal bevacizumab for neovascular glaucoma

被引：9
作者：
Jonas, Jost B. [1 ]
Golubkina, Lidia [1 ]
Libondi, Teodosio [1 ,2 ]
Rensch, Florian [1 ]
机构：
[1] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany
[2] Univ Naples 2, Dept Ophthalmol, Naples, Italy
来源：
ACTA OPHTHALMOLOGICA | 2010年 / 88卷 / 02期
关键词：
PANRETINAL PHOTOCOAGULATION; INTRACAMERAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; INJECTION; AVASTIN; RETINOPATHY;
D O I：
10.1111/j.1755-3768.2008.01453.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：e22 / e23
页数：2
相关论文
共 20 条
  • [1] A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
    Algvere, Peep V.
    Steen, Bjoern
    Seregard, Stefan
    Kvanta, Anders
    [J]. ACTA OPHTHALMOLOGICA, 2008, 86 (05) : 482 - 489
  • [2] Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
    Arevalo, J. F.
    Maia, M.
    Flynn, H. W., Jr.
    Saravia, M.
    Avery, R. L.
    Wu, L.
    Farah, M. Eid
    Pieramici, D. J.
    Berrocal, M. H.
    Sanchez, J. G.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (02) : 213 - 216
  • [3] Intravitreal bevacizumab (Avastin®) for radiation retinopathy neovascularization
    Arriola-Vilialobos, Pedro
    Donate-Lopez, Juan
    Calvo-Gonzalez, Cristina
    Reche-Frutos, Juan
    Alejandre-Alba, Nicolas
    Diaz-Valle, David
    [J]. ACTA OPHTHALMOLOGICA, 2008, 86 (01) : 115 - 116
  • [4] Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma
    Chalam, K. V.
    Gupta, S. K.
    Grover, S.
    Brar, V. S.
    Agarwal, S.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (02) : 255 - 262
  • [5] Bevacizumab (Avastin) for the treatment of neovascular glaucoma
    Chilov, Michael N.
    Grigg, John R.
    Playfair, T. Justin
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (05) : 494 - 496
  • [6] Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity
    dell'Omo, Roberto
    Kulkarni, Avinash
    Franks, Wendy A.
    [J]. ACTA OPHTHALMOLOGICA, 2008, 86 (06) : 698 - 700
  • [7] Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma
    Ehlers, Justis P.
    Spirn, Marc J.
    Lam, Andrew
    Sivalingam, Arunan
    Samuel, Michael A.
    Tasman, William
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (05): : 696 - 702
  • [8] Role of intravitreal bevacizumab in neovascular glaucoma
    Gheith, Moataz E.
    Siam, Ghada A.
    De Barros, Daniela S. Monteiro
    Garg, Sunir J.
    Moster, Marlene R.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (05) : 487 - 491
  • [9] Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
    Grover, S.
    Gupta, S.
    Sharma, R.
    Brar, V. S.
    Chalam, K. V.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) : 273 - 274
  • [10] Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
    Iliev, Milko E.
    Domig, Diego
    Wolf-Schnurrbursch, Ute
    Wolf, Sebastian
    Sarra, Gian-Marco
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (06) : 1054 - 1056
12